Sirio Pharma Co., Ltd. / Fundamentals
Income statement
- Net revenue
€515.84M - Cost of goods sold
€350.69M - Gross profit
€165.15M - SG&A expenses
€40.02M - R&D expenses
€14.62M - EBITDA
€44.95M - D&A
€0.00 - EBIT
€39.61M - Interest expenses
€9.00M - EBT
€35.95M - Tax expenses
€1.77M - Net income
€40.15M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€29.13M - Changes in working capital
€0.00 - Operating cash flow
€39.46M - Capex
€51.83M - Other investing cash flow
-€3.26M - Net investing cash flow
-€55.42M - Total cash dividends paid
-€21.89M - Issuance of common stock
€0.00 - Debt repayment
€7.29M - Other financing cash flow
€5.76M - Net financing cash flow
-€8.85M - Foreign exchange effects
€1.38M - Net change in cash
€11.22M - Cash at end of period
€69.75M - Free cash flow
€91.29M
Balance sheet
- Cash and cash equivalents
€70.13M - Cash and short-term investments
€70.18M - Total receivables
€94.85M - Inventory
€70.06M - Other current assets
€6.20M - Total current assets
€241.29M - Property, plant & equipment
€260.78M - Goodwill
€52.69M - Intangible assets
€67.69M - Long-term investments
€0.00 - Other non-current assets
€58.91M - Total non-current assets
€452.85M - Total assets
€694.13M - Accounts payable
€53.69M - Short-term debt
€21.47M - Other current liabilities
€43.96M - Total current liabilities
€125.18M - Long-term debt
€180.45M - Deferred tax liabilities
€1.61M - Other non-current liabilities
€55.62M - Total non-current liabilities
€246.56M - Total liabilities
€371.74M - Common stock
€37.19M - Retained earnings
€184.40M - Other equity
€0.00 - Total equity
€322.39M - Total liabilities and shareholders' equity
€694.13M
Company information
- Market capitalization
€863.20M - Employees
2.6K - Enterprise Value
€9.31B
Company ratios
- Gross margin
-
32.0% Worse than peer group: 48.1% - EBITDA margin
-
8.7% Worse than peer group: 21.2% - EBIT margin
-
7.7% Worse than peer group: 18.9% - EBT margin
-
7.0% Worse than peer group: 19.4% - Net margin
-
7.8% Worse than peer group: 16.6% - ROE
-
12.5% Even with peer group: 10.6% - ROA
-
5.8% Even with peer group: 8.4% - Asset turnover
-
74.3% Better than peer group: 61.8% - FCF margin
-
-2.4% Worse than peer group: 4.8% - FCF yield
-1.4% - Efficiency ratio
91.3% - Net sales per employee
-
€197.64K - Net income per employee
-
€15.38K